Short Interest in Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Decreases By 13.5%

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) saw a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 3,200 shares, a decline of 13.5% from the August 31st total of 3,700 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Kissei Pharmaceutical Price Performance

Shares of OTCMKTS:KSPHF opened at $21.48 on Friday. The business has a fifty day simple moving average of $21.09 and a 200-day simple moving average of $21.49. Kissei Pharmaceutical has a 52 week low of $19.32 and a 52 week high of $21.48.

Kissei Pharmaceutical Company Profile

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.